Full text
PDF
. 1965 May;55(5):703–707. doi: 10.2105/ajph.55.5.703
Problems Raised for the FDA By the Occurrence of Thalidomide Embryopathy in Germany, 1960-1961
Frances O Kelsey
1
Frances O Kelsey, Ph.D., M.D.
1Investigational Drug Branch, Division of New Drugs, Bureau of Medicine, Food and Drug Administration, Department of Health, Education, and Welfare, Washington, D. C.
Chief
Find articles by Frances O Kelsey
1Investigational Drug Branch, Division of New Drugs, Bureau of Medicine, Food and Drug Administration, Department of Health, Education, and Welfare, Washington, D. C.
Roles
Frances O Kelsey: Ph.D., M.D., Chief
PMCID: PMC1256300 PMID: 14287841